TumorGraft- Guided Therapy for Improved Outcomes in Head and Neck Squamous Cell Cancer- A Feasibility Study
- Status
- COMPLETED
- Phase
- NA
Clinical Trials Related to Head and Neck Squamous Cell Carcinoma
Related studies linked through entity extraction aliases.
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
- Status
- RECRUITING
- Phase
- PHASE2
BGJ398 in Treating Patients With FGFR Positive Recurrent Head and Neck Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Head and Neck Squamous Cell Carcinoma (HNSCC)PET-CT Pilot Study
- Status
- RECRUITING
- Phase
- NA
DAHANCA 30: A Randomized Non-inferiority Trial of Hypoxia-profile Guided Hypoxic Modification of Radiotherapy of HNSCC.
- Status
- UNKNOWN
- Phase
- PHASE3
A Study of Tremelimumab and IV Durvalumab Plus Poly-ICLC in Subjects With Biopsy-accessible Cancers
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study to Evaluate the Efficacy and Safety of Docetaxel Polymeric Micelle (PM) in Recurrent or Metastatic HNSCC
- Status
- UNKNOWN
- Phase
- PHASE2
Chemoprevention of Head and Neck Squamous Cell Carcinoma (HNSCC) With Valproic Acid
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Pharmacodynamic Effects and Predictive Biomarkers With Ruxolitinib in Operable Head and Neck Cancer
- Status
- WITHDRAWN
- Phase
- EARLY_PHASE1
Bupropion Hydrochloride or Patient's Choice for Smoking Cessation in Patients With Squamous Cell Head and Neck Cancer Undergoing Radiation Therapy With or Without Chemotherapy
- Status
- TERMINATED
- Phase
- EARLY_PHASE1
Testing the Addition of M6620 (VX-970, Berzosertib) to Usual Chemotherapy and Radiation for Head and Neck Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Talazoparib in Treating Patients With Advanced or Metastatic Solid Tumors That Cannot Be Removed by Surgery and Liver or Kidney Dysfunction
- Status
- WITHDRAWN
- Phase
- PHASE1
PDE5 Inhibition Via Tadalafil to Enhance Anti-Tumor Mucin 1 (MUC1) Vaccine Efficacy in Patients With HNSCC
- Status
- COMPLETED
- Phase
- PHASE1
Pembrolizumab and Vorinostat in Treating Patients With Recurrent Squamous Cell Head and Neck Cancer or Salivary Gland Cancer That Is Metastatic and/or Cannot Be Removed by Surgery
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Gabapentin, Methadone Hydrochloride, and Oxycodone Hydrochloride in Improving Quality of Life in Patients With Stage II-IV Head and Neck Cancer During Chemoradiation
- Status
- COMPLETED
- Phase
- PHASE1
Docetaxel and Capecitabine With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
- Status
- TERMINATED
- Phase
- PHASE2
WEE1 Inhibitor MK-1775, Docetaxel, and Cisplatin Before Surgery in Treating Patients With Borderline Resectable Stage III-IVB Squamous Cell Carcinoma of the Head and Neck
- Status
- COMPLETED
- Phase
- PHASE1
Reactivating NK Cells in Treating Refractory Head and Neck Cancer
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Recombinant EphB4-HSA Fusion Protein With Standard Chemotherapy Regimens in Treating Patients With Advanced or Metastatic Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Study of SCB01A in Patient With Head and Neck Cancer
- Status
- TERMINATED
- Phase
- PHASE2